scispace - formally typeset
A

Abbas Jafarizad

Researcher at Sahand University of Technology

Publications -  25
Citations -  366

Abbas Jafarizad is an academic researcher from Sahand University of Technology. The author has contributed to research in topics: Drug delivery & Medicine. The author has an hindex of 8, co-authored 22 publications receiving 237 citations. Previous affiliations of Abbas Jafarizad include Tabriz University of Medical Sciences & Atatürk University.

Papers
More filters
Journal ArticleDOI

Kinetic model for the isothermal activation of bentonite by sulfuric acid

TL;DR: In this paper, the activation mechanism of typical bentonite powder with sulfuric acid was studied from variations in their surface area during the reaction, and the surface area of activated samples at different activation temperatures and times were measured by methylene blue adsorption to quantify the effect of acid.
Journal ArticleDOI

Gold Nanoparticles and Reduced Graphene Oxide-Gold Nanoparticle Composite Materials as Covalent Drug Delivery Systems for Breast Cancer Treatment

TL;DR: The results demonstrate that SMTX-AuNPs have better activity on cancer cells than free MTX and SMTX/RGO and suggest that the use of graphene-based materials for the covalent drug delivery systems need to be revisited.
Journal ArticleDOI

Biosynthesis and In-vitro Study of Gold Nanoparticles Using Mentha and Pelargonium Extracts

TL;DR: By green synthesis method utilization and using two plants, Mentha and Pelargonium plant extracts, gold nanoparticles were synthesized. as discussed by the authors investigated reducing and stabilizing effects of mentioned plants, which was confirmed by GC-MS results.
Journal ArticleDOI

PEGylated graphene oxide/Fe3O4 nanocomposite: Synthesis, characterization, and evaluation of its performance as de novo drug delivery nanosystem.

TL;DR: According to biocompatibility, pH dependent drug release behavior as well as superior physicochemical and biological characteristics of graphene and magnetite nanoparticles, it is expected that the GO-PEG/Fe3O4 nanocomposite may be applied as de novo drug delivery system for cancer therapy using both chemo- and photothermal therapy approaches.